Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

Among liquid biopsy–based methodologies, cell-free DNA (cfDNA)–related early diagnosis technology is relatively mature, and relevant commercial detection kits have been approved. 8 The main ...

Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer The following represents disclosure information provided by authors of this manuscript.

A random sampling of cell-free DNA will consist of DNA from all chromosomes in proportion to their size—the largest chromosome being represented by the most segments, and so on—and therefore ...

This includes a late 2026-to-early-2027 release date and a price north of $2,000. That high price tag could be even higher, as Kuo ambiguously writes that it will be “above $2,000 and $2,500 ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation.

Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

Myriad Genetics' research allows prenatal cell-free DNA screening as early as eight weeks gestation, a significant advancement in prenatal genetic testing.

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...

Recently, cell-free DNA (cfDNA) fragmentomic features, which encompass fragment size, end motifs, breakpoint motifs, and nucleosome footprints, have demonstrated the potential of cfDNA fragmentomics ...